Xin Lang Cai Jing·2025-12-04 03:04Company Overview - Beijing Springli Zhengda Medical Devices Co., Ltd. is located in Tongzhou District, Beijing, and was established on February 12, 1998. The company went public on December 30, 2021. Its main business involves the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%. The net profit attributable to shareholders was 192 million yuan, showing a significant increase of 213.21% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders reached 6,164, an increase of 4.12% from the previous period. The average circulating shares per person decreased by 3.95% to 46,906 shares [2]. Dividend Distribution - Since its A-share listing, the company has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, Hong Kong Central Clearing Limited is the fourth largest shareholder with 2.9585 million shares, marking it as a new shareholder. Additionally, China Europe Economic Growth Mixed Fund A (020876) is the fifth largest with 2.8326 million shares, also a new shareholder. Ping An Low Carbon Economy Mixed Fund A (009878) is the eighth largest, holding 2.1 million shares, which is a decrease of 1.67 million shares from the previous period [3]. Financing and Margin Trading - On December 3, the company’s stock rose by 0.08% with a trading volume of 18.6315 million yuan. The financing data indicated a buying amount of 1.1477 million yuan and a repayment of 1.6993 million yuan, resulting in a net financing outflow of 0.5516 million yuan. The total margin trading balance reached 36.1091 million yuan, accounting for 0.51% of the market capitalization, which is above the 60th percentile of the past year [1].